期刊文献+

胆管细胞囊腺瘤 (癌) 的临床特征及诊治方法研究 被引量:1

Clinical features diagnosis and therapy of biliary cystadenoma and cystadenocarcinoma of liver
暂未订购
导出
摘要 目的了解胆管细胞囊腺瘤(癌)的发病情况,分析该病诊治特点。方法回顾性分析我院近10年来明确诊断的39例胆管细胞囊腺瘤(癌)患者的临床资料,对该病的发病率及诊断、治疗情况进行系统研究。结果胆管细胞囊腺瘤(癌)在肝脏占位性病变中约占0.35%,在肝脏囊实性占位中约占1.70%,手术切除后复发率为2.6%。结论胆管细胞囊腺瘤(癌)是一种少见的肝脏占位性病变,患者大多缺乏典型临床症状,影像学是主要的术前诊断方法,漏诊及误诊率高,对肿瘤实施完整手术切除是确切有效的治疗办法,术后复发率较低,预后较好。 Objective To study the incidence, clinical features diagnosis and therapy of biliary cystadenoma and cystadeno- carcinoma of the liver. Methods Those patients with liver tumor in the past 10 years were retrospectively analyzed, of them, 39 were diagnosed as having biliary eystadenoma or cystadenocarcinoma of the liver. Results The biliary cystadenoma or eystadenocareinoma of the liver comprised as few as 0.35% of space occupying lesions of liver , and 1.70% of cystic and solid hepatic tumors. Tumor relapsed in about 2.6% of patients who underwent tumor resectim. Conclusions The biliary eystadenoma or cystadenocarcinoma of the liver are rare tumors . Many of these patients do not have typical clinical symptoms,and were mostly diagnosed by imaging technology. But some of these patients missed diagnosis or are misdlagnozed. Tumor resection is an effective therapy for these diagnosed patients ; they can get good prognosis.
出处 《武警医学》 CAS 2010年第9期745-748,共4页 Medical Journal of the Chinese People's Armed Police Force
基金 国家传染病防治科技重大专项资助(2008ZX10002-26)
关键词 肝脏 囊腺瘤 囊腺癌 liver cystadenoma cystadenocarcinoma
  • 相关文献

参考文献2

二级参考文献19

  • 1Deha Erdogan,Olivier RC Busch,Erik AJ Rauws,Otto M van Delden,Dirk J Gouma,Thomas M van Gulik.Obstructive jaundice due to hepatobiliary cystadenoma or cystadenocarcinoma[J].World Journal of Gastroenterology,2006,12(35):5735-5738. 被引量:28
  • 2[1]Ishak KG,Willis GW,Cummins SD,Bullock AA.Biliary cystadenoma and cystadenocarcinoma:report of 14 cases and review of the literature.Cancer 1977; 39:322-338
  • 3[2]Devaney K,Goodman ZD,Ishak KG.Hepatobiliary cystadenoma and cystadenocarcinoma.A light microscopic and immunohistochemical study of 70 patients.Am J Surg Pathol 1994; 18:1078-1091
  • 4[3]den Hoed PT,Lameris H,Klooswijk B,IJzermans JN.Biliary cystadenoma:an uncommon cause of cholestatic jaundice.Eur J Surg Oncol 1999; 25:335-336
  • 5[4]Wang YJ,Lee SD,Lai KH,Wang SS,Lo KJ.Primary biliary cystic tumors of the liver.Am J Gastroenterol 1993; 88:599-603
  • 6[5]Thomas JA,Scriven MW,Puntis MC,Jasani B,Williams GT.Elevated serum CA 19-9 levels in hepatobiliary cystadenoma with mesenchymal stroma.Two case reports with immunohistochemical confirmation.Cancer 1992; 70:1841-1846
  • 7[6]Caturelli E,Bisceglia M,Villani MR,de Maio G,Siena DA.CA 19-9 production by a cystadenoma with mesenchymal stroma of the common hepatic duct:a case report.Liver 1998; 18:221-224
  • 8[7]Steinberg W.The clinical utility of the CA 19-9 tumorassociated antigen.Am J Gastroenterol 1990; 85:350-355
  • 9[8]Federle MP,Filly RA,Moss AA.Cystic hepatic neoplasms:complementary roles of CT and sonography.A JR Am J Roentgenol 1981; 136:345-348
  • 10[9]Palacios E,Shannon M,Solomon C,Guzman M.Biliary cystadenoma:ultrasound,CT,and MRI.Gastrointest Radiol 1990; 15:313-316

共引文献29

同被引文献6

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部